Psychiatry & Neurology Doctors in Olympia, WA Accepting Medicare

45 Psychiatry & Neurology doctors found. Showing 41 - 45

Geoffrey A Ankeney, M.D. Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 700 Lilly Rd Ne, Olympia, WA 98506 Phone: 360-923-7000

Dr. Alan Francis Javel, MD Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 2608 Pacific Ave, Suite F, Olympia, WA 98501 Phone: 360-943-9797    Fax: 360-943-9797

Gary Franklin, Psychiatry & Neurology - Neurology Medicare: Not Enrolled in Medicare Practice Location: 525 Lilly Rd Ne # 210, Olympia, WA 98506 Phone: 360-413-8550

James Douglas Bremner, M.D. Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 2103 Harrison Ave Nw # 2791, Olympia, WA 98502 Phone: 360-867-4949    Fax: 360-867-9771

Dr. Ryan K. Louie, M.D., PH.D. Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 700 Lilly Rd Ne, Olympia, WA 98506 Phone: 360-923-7000

News Archive

Simple measures to prevent weight gain over Christmas

Christmas time is usually a time of indulgence that leads to unwanted weight gain. A new study has shown that if simple weight loss tips are followed and individuals weigh themselves regularly at home, this weight gain can be avoided.

Steven Schiff wins NIH Director's Pioneer Award to reduce infant deaths from neonatal sepsis

Steven Schiff, professor of neurosurgery and Brush Chair Professor of Engineering in Engineering Science and Mechanics, has received a $4.1 million National Institutes of Health Director's Pioneer Award, for research aimed at reducing the number of infant deaths from neonatal sepsis in developing countries by identifying the roots of infection, from season of birth to home environment.

Study to assess voluntary HIV testing, prompt treatment in South Africa, Zambia

A study in South Africa and Zambia will assess whether house-to-house voluntary HIV testing and prompt treatment of HIV infection, along with other proven HIV prevention measures, can substantially reduce the number of new HIV infections across communities.

STERIS reaches agreement with FDA over liquid chemical sterilization system consent decree

STERIS Corporation today announced it has reached an agreement with the U.S. Food and Drug Administration (FDA) on the terms of a consent decree regarding its SYSTEM 1® liquid chemical sterilization system. Included in the agreement is a Transition Plan with a Rebate Program for current SYSTEM 1 Customers in the U.S. The consent decree is subject to approval by the U.S. District Court for the Northern District of Ohio.

Read more Medical News

› Verified 5 days ago

• 1
• 2
• 3(current)